The study analyses the performance of Indian pharmacological research during the last ten years (2003-12) using publications data covered in Scopus database, based on several parameters including global publication share and rank of 15 most productive countries, India's publication growth rate and citations impact, its pattern of citations output,international collaboration profile, institutional profile, geographical distribution of output, contribution and impact of top institutions and authors, pattern of communications and characterstics of high cited papers.
INTRODUCTION
The pharmaceutical industry is growing in the entire world and is regarded as one of the most profitable industry. The pharmacy profession has evolved over the past in response to the growth in medication use and patients' demand. Today, pharmacy profession is considered as one of the most preferable and respectable profession. Pharmacy has changed and continues to change even as health care delivery systems change. around us. Pharmacy is the science concerned with therapeutic substances -their discovery, origin and nature, their development into medicines and their use in disease prevention and treatment. Pharmacy also denotes the profession which uses its unique knowledge of medicines in the service of society. The present pharmacists' role and responsibility does not lie merely in dispensing of medication but in the provision of patient focus care such as providing drug information and drug therapy recommendation i.e. pharmacists' are also the primary health professionals. Those invoved in pharmacologyresearch are concerned with synthesis of new drugs (what is commonly referred as molecules), new processes, clinical testing of the effects of such drugs on animals and humans and obtaining the required lincense from drug control authorities.
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In India, formal pharmacy education leading to a degree began with the introduction of a 3-year bachelor of pharmacy (BPharm) at Banaras Hindu University in 1937. Before India gained independence in 1947, there were 3 institutions offering pharmacy degree programs. In 1944, the Punjab University started a pharmacy department; in 1947 L.M. College was established in Ahmedabad. At independence in 1947, India inherited a system for the pharmacy profession from the British rulers that was unorganized and there was no legal restriction on the practice of pharmacy. The concept of pharmacy practice was not realized until after independence was gained. In 1948, the Pharmacy Act 5 was enacted as the nation's first minimum standard of educational qualification for pharmacy practice to regulate the practice, education, and profession of pharmacy. Currently, one needs at least a diploma in pharmacy to practice as a pharmacist. Provisions of the Act are implemented through the Pharmacy Council of India (PCI). 6 The Act requires individual states to establish state pharmacy councils that are responsible for controlling and registering pharmacists in their respective states. A variety of pharmacy degree programs are offered in India at present. Diploma in Pharmacy (D. Pharm, 2 years course) is the minimum qualification required to be a registered pharmacist in India. B. Pharm (4 years course) is offered in various universities. Some Universities also offer Pharm.D (6 years course). The first batch of Pharm.D students will graduate by 2011. Pharmacy Council of India permitted few universities to start Pharm.D (post baccalaureate) (2 years + 1 full working year internship in a 300 bedded hospital) for B pharmacy graduates. To practice as a pharmacist in India, one needs at least a Diploma in Pharmacy (DPharm), which is awarded after only 2 years and 3 months of pharmacy studies. The growth of pharmacology research was rapid after 1950 in India with the opening of new medical colleges and developing postgraduate facilities at several centres, followed in due course with new institutions in pharmacy & veterinary medicine and further aided further by opening of new national laboratories such Central Drug Research Institute at Lucknow and industrial research centres of CIBA, Hoechst, Ranbaxy, Dr Reddy's, etc. The growth was substantially helped later with the return of many pharmacologists trained abroad, provision of fellowship by agencies like Rockfeller Foundation and WHO for training abroad and within the country, and establishment of specialized units and centres of advanced research by ICMR, CSIR, DBT, DST, etc.The Drugs & Pharmaceuticals Research Programme (DPRP) was initiated by DST in 1994-95 for promoting industryinstitutional collaboration in drugs & pharmaceutical sector which aimed at enhancing capabilities of R&D institutions and industrialin units towards development of new drugs. Presently, apart from strengthening intellectual property protection system, government is providing soft loans, grants and tax benefits to promote R&D activities. Public-Private Partnerships (PPPs) initiated by DST and CSIR are providing avenues for risk sharing and better collaboration between public research facilities and private sector for development of NCEs. Presently most of the pharmaceutical R&D is carried out by private sector companies, with major R&D spenders like Dr. Reddy's laboratories, Glenmark and Piramal enterprises spending 7-8% of total income in 2013 in R&D. The Department of Pharmaceuticals in the Ministry of Chemicals & Ferlizers was created on 1.7.2008for coordination of activities in the pharmacy profession at the national level, including R&D activities.
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The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 90% of the country's pharmaceuticals needs for bulk drugs, drug intermediates and formulations. The annual turnover of the Indian pharmaceutical industry is estimated to have increased from 61219 crores to 104209 crores from 2006 to 2010. Globally, the Indian pharmaceutical industry ranks 4 th in terms of volume (8% market share) and 13 th in terms of value (with share of 1% in global sales). Large, medium & small pharma players totaling about 24000 manufacturing units are in India employing about 1.5 million people.Indian pharma companies produce about 20-22% of the world's generic drugs (in terms of value).
Literature Review
A few evaluative studies have been carried out in the past on contribution of impact of pharmacological research measured in terms of publications output on global scale 5, 6 , regional level 7, 8 , as well as on specific countries such as India 9 , China 10 , Saudi Arabia 11 and Spain. 12 The present study makes an extensive evalution of pharmacological research in India for last ten years (2003-12), using Scopus database
Objectives
The main objectives of this study are to analyze the research performance of India in pharmacologicalresearch during 2003-12, based on publications output, as covered and indexed in Scopus database. In particular, the study focuses on the following objectives: to study the global contribution, share and rank of top 15 most productive countries in pharmacology; (i) To study the growth, citation impact anof international collaboration of Indian publications in pharmacology; (ii)
To study the patterns of citation distribution and characterstics of India's high cited papers; (iii)
To study the the trends in pharmacological research in India, using significant keywors; (iv)
To study the geographical distribution of Indian pharmacological research papers; (v)
To study the contribution and impact of different types of Indian organications; (vi)
To study the contribution and impact of top 30 Indian institutions and authors inpharmacology; and (vii)
To study and identify the the major Indian and foreign journals contributing to Indian pharmacological research.
Methdology
The study is based on publication data on pharmacological research retrieved from Scopus database (http://www.scopus.com) for 10 years from 2003 to 2012. The study identified publications in pharmacology, using Scopus database classification of subjects. First India is searched in "Affiliation" field during the period tag "2003-2012" and the output was further limited to "pharmacology" subject tag. This become our main string for searching data on India and 14 other most productive countries. For generating citation impact data, the three years, two years, one year citation window was used for publications during 2003-10, 2011 and 2012. For searching the international collaborative papers, the main search strategy was restricted to further "country" tag for identifying India's collaborating countries and significant collaborating partners. For analyzing institutional, author and journals output, the separate search strategies were developed which later combined with the main search string to generate the desired output.
ANALYSIS

Global Contribution of Top 15 Most productive Countries
The global publication share of top 15 most productive countries in pharmacological research varied from 1.44% to 25.04% during 2003-12. The United States tops the list with global publication share of 25.04% (1 st rank), followed far behind by China (9.51% share and second rank), India (7.52% share and third rank), Japan, U.K., Germany, Italy and France (their global publication share ranging from 4.32% to 7.39% and rank from 4 th to 8 th ), Canada, Spain, South Korea and Brazil (their global publication share ranging from 2.17% to 2.46% and rank from 9 th to 12 th ) and Australia, Netherlands and Switzerland (their global publica- 
Pattern of Citation Distribution of Indian Output
Of the total Indian pharmacological output, 47.97% papers received no or zero citations, in contrast to 52.03% papers receiving citations from 1 to 705 during 2003-2012 since their publication till the end of 20113. Of the total cited papers, 29.77% (25254 papers) received from 1-9 citations, 11.53% (6070 papers) (Table 4) .
Geographical Distribution of Indian Pharmacological Output
Nearly all Indian geographical regions are partcipitating in Indian pharmacological research output during 2003-12. The largest contribution to Indian pharmacological output comes from Maharashtra with 13.46% share, followed by Andhra Andhra Pradesh (11.79% share), Tamil Nadu (10.49% share), Karnataka (10.21% share), Uttar Pradesh (10.21% share), Delhi (7.58% share), Gujarat, Madhya Pradesh, Rajasthan and Panjab (between 3.75% to 5.96% share), Chandiagarh (2.40% share), Kerala (2.09%) and other states less than 1% share dur- On studying the focus of pharmacological research by different body system, the largest number of papers came from nervous system (with 813 papers), followed by gastriintenstinal system (711 papers), immune system (510 papers), cardiovascular or circulatory system (388 papers), respiratory system (258 papers), reproductive system (155 papers), urinary system (133 papers), endocrine system (77 papers), musculoskclion system (36 papers) and integumentary system (2 papers) during 2003-12.
On analyzing the focus of pharmacological research by disease, the largest number of papers was on cancer (with 4020 papers), followed by diabetes (3512 papers), heart diseases (2824 papers), liver disease (1311 papers), tuberculosis (858 papers), measles (855 papers), diarrhea (831 papers), arthritis (806 papers), AIDS/HIV (744 papers), asthma (658 papers), hepatitis (563 papers), malaria (501 papers), blood disease (499 papers), allergy (440 papers), epilepsy (373 papers), etc during 2003-12 (Table 8) On analyzing the focus of pharmacological research by type of biological activity, the largest number of papers were on observed on antioxidant activity (with 3755 papers), followed by enzyme activity (3212 papers), anti- 
